Report cover image

Grupo Ferrer Internacional SA - Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI’s, and Recent Trends

Publisher Quaintel Research
Published Dec 12, 2025
Length 80 Pages
SKU # QTELR20682717

Description

Report Summary

Grupo Ferrer Internacional SA Strategic SWOT Analysis and Financial Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Grupo Ferrer Internacional SA's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Grupo Ferrer Internacional SA including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Grupo Ferrer Internacional SA's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Grupo Ferrer Internacional SA's overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Grupo Ferrer Internacional SA's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Grupo Ferrer Internacional SA's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.

Finally, the report includes recent news and deal activities undertaken by Grupo Ferrer Internacional SA enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Grupo Ferrer Internacional SA is a multinational pharmaceutical and healthcare company headquartered in Barcelona, Spain. Founded in 1959, rupoz Ferrer operates across a diverse range of segments, including pharmaceuticals, consumer healthcare, and diagnostics. The company's pharmaceutical division focuses on developing and marketing prescription medications in areas such as cardiology, neurology, and dermatology. Its consumer healthcare segment offers over-the-counter (OTC) products, including dietary supplements and wellness solutions. Additionally, Grupo Ferrer is involved in diagnostics through its innovative medical technologies and laboratory solutions. The company has a significant international presence, extending its operations to over 90 countries worldwide. This extensive geographic reach allows Grupo Ferrer to cater to a broad range of markets and adapt its offerings to meet local healthcare needs. Its global operations are supported by a robust network of subsidiaries and partners, ensuring that its products and services are accessible to a diverse customer base. Grupo Ferrer's commitment to innovation, quality, and sustainability drives its mission to improve health outcomes and enhance the quality of life for individuals around the globe.

Grupo Ferrer Internacional SA in the News:-

2025-07-25 - Prilenia and Ferrer Provide Update on European Regulatory Process for Pridopidine in Huntington s Disease

2025-07-18 - Ferrer strengthens its impact in 2024 with increased social and environmental investment, B Corp leadership and sustainability progress

2025-06-17 - We Receive FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)

2025-03-31 - Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management

2025-02-20 - We are the highest-rated pharma B Corp in the world

Scope
  • Tactical Analysis:- Various strategic frameworks to gain insights into a Grupo Ferrer Internacional SA's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
  • Business Strategy:- Contributes to shaping the Grupo Ferrer Internacional SA's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
  • Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
  • Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
  • Competitive Landscape:- An identification of the Grupo Ferrer Internacional SA's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
  • Comprehensive Understanding of the Grupo Ferrer Internacional SA's internal and external factors through SWOT analysis, Financial Analysis, and Competitors Benchmarking.
  • Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
  • Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
  • Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
  • Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
  • Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Grupo Ferrer Internacional SA:
  • Grupo Ferrer Internacional SA PESTLE Analysis
  • Grupo Ferrer Internacional SA Value Chain Analysis
  • Grupo Ferrer Internacional SA Porter's Five Forces Analysis
  • Grupo Ferrer Internacional SA VRIO Analysis
  • Grupo Ferrer Internacional SA BCG Analysis
  • Grupo Ferrer Internacional SA Segmentation, Targeting and Positioning (STP) Analysis
  • Grupo Ferrer Internacional SA Ansoff Matrix Analysis

Table of Contents

80 Pages
Tables
Charts
Grupo Ferrer Internacional SA - Key Company Facts
Grupo Ferrer Internacional SA - Company Description
Grupo Ferrer Internacional SA - Top Executives
Grupo Ferrer Internacional SA - Top Executives Biographies
Grupo Ferrer Internacional SA - Head Office & Locations
Head Office - Country
Key Subsidiaries
Grupo Ferrer Internacional SA - Products and Services
Products
Services
Grupo Ferrer Internacional SA - Historic Events
Grupo Ferrer Internacional SA - Corporate Strategy
Grupo Ferrer Internacional SA - Business Description
Fine Chemicals and Industrial Products
Prescription Pharmaceuticals
Grupo Ferrer Internacional SA - ESG Spotlight
Environment
Social
Corporate Governance
Grupo Ferrer Internacional SA - SWOT Analysis
Overview
Strengths
Weaknesses
Opportunities
Threats
Competing Players
Snapshot of Competing Players
Almirall SA
Key Company Facts
Company Description
Key Financials
Share Price Trend - Jan-2024 to Dec-2025 (Average Share Closing Price)
Key Financial Ratio Analysis
Hikma Pharmaceuticals PLC
Key Company Facts
Company Description
Key Financials
Share Price Trend - Jan-2024 to Dec-2025 (Average Share Closing Price)
Grunenthal GmbH
Key Company Facts
Company Description
Neuraxpharm Arzneimittel GmbH
Key Company Facts
Company Description
Grupo Ferrer Internacional SA - In the News
25-Jul-2025- Prilenia and Ferrer Provide Update on European Regulatory Process for Pridopidine in Huntington’s Disease
18-Jul-2025- Ferrer strengthens its impact in 2024 with increased social and environmental investment, B Corp leadership and sustainability progress
17-Jun-2025- We Receive FDA Fast Track Designation for FNP-223 in Progressive Supranuclear Palsy (PSP)
31-Mar-2025- Experts Set International and Multidisciplinary Collaboration As Priorities in Pulmonary Hypertension Management
20-Feb-2025- We are the highest-rated pharma B Corp in the world
30-Jan-2025- Ferrer is recognized for its best-in-class ethics and compliance program
20-Nov-2024- We spearhead two European studies that highlight the urgency of patients and experts to improve the diagnosis and treatment of pulmonary hypertension associated with interstitial lung disease
27-May-2024- Ferrer obtains the distribution rights of a potential treatment for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF)
21-Apr-2024- People living with pulmonary hypertension call for better psychological support in the absence of awareness of this severe disease
06-Feb-2024- CDP rates us among the leading companies in the fight against climate change
10-Jan-2024- Ferrer reports top-line results from Phase III ADORE study in ALS
Grupo Ferrer Internacional SA - Key Deals
28-Apr-2025 - We enter into a collaboration and license agreement with Prilenia for the commercialization and co-development of Pridopidine
Appendix
Definitions
SWOT Analysis
PESTLE Analysis
Value Chain Analysis
ESG Spotlight
Research Methodology
Disclaimer
Contact Us

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.